Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis

被引：0
|
作者：
Yuying Han
Xu Liu
Haihong Ye
Ye Tian
Zhengguo Ji
机构：
[1] Capital Medical University,Department of Medical Genetics and Developmental Biology, School of Basic Medical Sciences, Beijing Key Laboratory of Neural Regeneration and Repair
[2] Capital Medical University,Department of Urology, Beijing Friendship Hospital
来源：
World Journal of Surgical Oncology | / 18卷
关键词：
Mutant-allele tumor heterogeneity; Prognosis; Bladder cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 31 条
  • [1] Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis
    Han, Yuying
    Liu, Xu
    Ye, Haihong
    Tian, Ye
    Ji, Zhengguo
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2020, 18 (01)
  • [2] Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer
    Ding Ma
    Yi-Zhou Jiang
    Xi-Yu Liu
    Yi-Rong Liu
    Zhi-Ming Shao
    [J]. Breast Cancer Research and Treatment, 2017, 162 : 39 - 48
  • [3] Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer
    Ma, Ding
    Jiang, Yi-Zhou
    Liu, Xi-Yu
    Liu, Yi-Rong
    Shao, Zhi-Ming
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 162 (01) : 39 - 48
  • [4] Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma
    Wu, Xiaoxuan
    Song, Peng
    Guo, Lei
    Ying, Jianming
    Li, Wenbin
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer
    Rajput, Ashwani
    Bocklage, Therese
    Greenbaum, Alissa
    Lee, Ji-Hyun
    Ness, Scott A.
    [J]. CLINICAL COLORECTAL CANCER, 2017, 16 (03) : E165 - E170
  • [6] Clinical relevance of mutant-allele tumor heterogeneity and lung adenocarcinoma
    Mao, Hengyu
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (18)
  • [7] Mutant-Allele Tumor Heterogeneity (MATH) Scores Correlate with Stage of Colon Cancer
    Rajput, A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S92 - S92
  • [8] Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
    Hou, Yufang
    Li, Tiegang
    Gan, Wenqiang
    Lv, Silin
    Zeng, Zifan
    Yan, Zheng
    Wang, Weiqi
    Yang, Min
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [9] Mutant-allele tumor heterogeneity in malignant glioma effectively predicts neoplastic recurrence
    Wu, Pengfei
    Yang, Wei
    Ma, Jianxing
    Zhang, Jingyu
    Liao, Maojun
    Xu, Lunshan
    Xu, Minhui
    Yi, Liang
    [J]. ONCOLOGY LETTERS, 2019, 18 (06) : 6108 - 6116
  • [10] FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression
    Okato, Atsushi
    Utsumi, Takanobu
    Ranieri, Michela
    Zheng, Xingnan
    Zhou, Mi
    Pereira, Luiza D.
    Chen, Ting
    Kita, Yuki
    Wu, Di
    Hyun, Hyesun
    Lee, Hyojin
    Gdowski, Andrew S.
    Raupp, John D.
    Clark-Garvey, Sean
    Manocha, Ujjawal
    Chafitz, Alison
    Sherman, Fiona
    Stephens, Janaye
    Rose, Tracy L.
    Milowsky, Matthew I.
    Wobker, Sara E.
    Serody, Jonathan S.
    Damrauer, Jeffrey S.
    Wong, Kwok-Kin
    Kim, William Y.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (02):
1234